NEWS & EVENTS
Agonist Redirected Checkpoint Platform (ARC); Engineering Bi-Functional Fusion Proteins (SIRPĪ±-Fc-CD40L), for Cancer Immunotherapy

SITC 2018

Read more
Agonist Redirected Checkpoint Platform (ARC); Engineering Bi-Functional Fusion Proteins (TIM3-Fc-OX40L and TIM3-Fc-CD40L), for Cancer Immunotherapy

SITC 2018

Read more